{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:05:28Z","timestamp":1793221528859,"version":"4.5.0"},"reference-count":279,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS100529"],"award-info":[{"award-number":["R01NS100529"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13311-019-00782-9","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:03:50Z","timestamp":1568635430000},"page":"957-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models"],"prefix":"10.1016","volume":"16","author":[{"given":"Jordi","family":"Creus-Muncunill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-019-00782-9_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"HDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00782-9_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-019-00782-9_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JHD-130082","article-title":"Huntingtin: here, there, everywhere!","volume":"2","author":"Marques Sousa","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.1007\/s13311-019-00782-9_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00001756-200402090-00030","article-title":"Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study","volume":"15","author":"Kassubek","year":"2004","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-019-00782-9_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-019-00782-9_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-019-00782-9_bib9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2018.11","article-title":"Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities","volume":"39","author":"Harding","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1007\/s13311-019-00782-9_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","article-title":"Ubiquitin-proteasome system involvement in Huntington's disease","volume":"7","author":"Ortega","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet"},{"key":"10.1007\/s13311-019-00782-9_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015245","article-title":"Formation and toxicity of soluble polyglutamine oligomers in living cells.","volume":"5","author":"Lajoie","year":"2010","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1007\/s13311-019-00782-9_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(02)00450-3","article-title":"Insoluble TATA-binding protein accumulation in Huntington's disease cortex","volume":"109","author":"Van Roon-Mom","year":"2002","journal-title":"Mol Brain Res"},{"key":"10.1007\/s13311-019-00782-9_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins: Mechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol Cell"},{"key":"10.1007\/s13311-019-00782-9_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1083\/jcb.153.2.283","article-title":"Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression","volume":"153","author":"Suhr","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-019-00782-9_bib18","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10863-010-9287-6","article-title":"Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration","volume":"42","author":"Oliveira","year":"2010","journal-title":"J Bioenerg Biomembr"},{"key":"10.1007\/s13311-019-00782-9_bib20","first-page":"195","article-title":"Neurotrophic factors in Huntington's disease","volume":"146","author":"Alberch","year":"2004","journal-title":"Prog Brain Res"},{"key":"10.1007\/s13311-019-00782-9_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-019-00782-9_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1566-2772(03)00054-9","article-title":"Excitotoxicity in Huntington disease","volume":"3","author":"Raymond","year":"2003","journal-title":"Clin Neurosci Res"},{"key":"10.1007\/s13311-019-00782-9_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington's disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog Brain Res"},{"key":"10.1007\/s13311-019-00782-9_bib24","first-page":"493","article-title":"Exon 1 of the HD Gene with an","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Expanded."},{"key":"10.1007\/s13311-019-00782-9_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2014.00295","article-title":"Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease","volume":"8","author":"Francelle","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib26","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease","volume":"29","author":"Cummings","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib28","first-page":"2621","article-title":"Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease","volume":"25","author":"Teo","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib29","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington's disease","volume":"33","author":"Simmons","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib30","doi-asserted-by":"crossref","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","article-title":"RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"10","author":"Labadorf","year":"2015","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib31","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","article-title":"A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin","volume":"22","author":"Damiano","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib32","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.celrep.2017.12.013","article-title":"Reconstituting corticostriatal network on-a-chip reveals the contribution of the presynaptic compartment to Huntington's disease","volume":"22","author":"Virlogeux","year":"2018","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib34","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib36","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/hmg\/ddn206","article-title":"Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse","volume":"17","author":"Brown","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib37","doi-asserted-by":"crossref","first-page":"e00060","DOI":"10.1042\/AN20110009","article-title":"Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function","volume":"3","author":"Kim","year":"2011","journal-title":"ASN Neuro"},{"key":"10.1007\/s13311-019-00782-9_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1007\/s13311-019-00782-9_bib39","first-page":"487","article-title":"Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model","volume":"28","author":"Wood","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib40","first-page":"1","article-title":"Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice","volume":"00","author":"Petkau","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib41","first-page":"1","article-title":"Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in","author":"Ferrari","year":"2019","journal-title":"Huntington disease."},{"key":"10.1007\/s13311-019-00782-9_bib42","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib44","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes","volume":"85","author":"Huang","year":"2015","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00782-9_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib47","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice","volume":"22","author":"Menalled","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","article-title":"Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease","volume":"2","author":"Gu","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-019-00782-9_bib51","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in Huntington's disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nicl.2016.02.014","article-title":"Linking white matter and deep gray matter alterations in premanifest Huntington disease","volume":"11","author":"Faria","year":"2016","journal-title":"NeuroImage Clin"},{"key":"10.1007\/s13311-019-00782-9_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib55","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib56","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4522(00)00020-8","article-title":"Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies","volume":"97","author":"Ouary","year":"2000","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-019-00782-9_bib58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JHD-150149","article-title":"Mass spectrometry analysis of wild-type and knock-in Q140\/Q140 Huntington's disease mouse brains reveals changes in glycerophospholipids including alterations in phosphatidic acid and lyso-phosphatidic acid","volume":"4","author":"Vodicka","year":"2015","journal-title":"J Huntingtons Dis"},{"key":"10.1007\/s13311-019-00782-9_bib60","doi-asserted-by":"crossref","first-page":"e7435","DOI":"10.15252\/msb.20167435","article-title":"Transcriptional regulatory networks underlying gene expression changes in Huntington's disease","volume":"14","author":"Ament","year":"2018","journal-title":"Mol Syst Biol"},{"key":"10.1007\/s13311-019-00782-9_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.2012.07925.x","article-title":"Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin","volume":"123","author":"Jin","year":"2012","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-019-00782-9_bib62","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/pr200839d","article-title":"Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese","volume":"11","author":"Wegrzynowicz","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1007\/s13311-019-00782-9_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jprot.2015.11.007","article-title":"Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology","volume":"132","author":"Choudhury","year":"2016","journal-title":"J Proteome"},{"key":"10.1007\/s13311-019-00782-9_bib64","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","article-title":"Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human Huntington's disease neural stem cells","volume":"5","author":"Ring","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cels.2018.05.010","article-title":"High-throughput functional analysis distinguishes pathogenic, nonpathogenic, and compensatory transcriptional changes in neurodegeneration","volume":"7","author":"Al-Ramahi","year":"2018","journal-title":"Cell Syst"},{"key":"10.1007\/s13311-019-00782-9_bib66","first-page":"609","article-title":"Expression analysis of novel striatal-enriched genes in","volume":"19","author":"Mazarei","year":"2010","journal-title":"Huntington disease."},{"key":"10.1007\/s13311-019-00782-9_bib67","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-\u03b2","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib68","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8571.1","article-title":"Molecular underpinnings of neurodegenerative disorders: striatal-enriched protein tyrosine phosphatase signaling and synaptic plasticity.","volume":"5","author":"Lombroso","year":"2016","journal-title":"F1000Research."},{"key":"10.1007\/s13311-019-00782-9_bib69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jnc.13160","article-title":"Striatal-enriched protein tyrosine phosphatase regulates the PTPalpha\/Fyn signaling pathway","volume":"134","author":"Xu","year":"2015","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-019-00782-9_bib70","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1523\/JNEUROSCI.3446-10.2011","article-title":"Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity","volume":"31","author":"Saavedra","year":"2011","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nbd.2018.08.024","article-title":"Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease","volume":"120","author":"Garcia-Forn","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib72","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1093\/hmg\/dds154","article-title":"Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model","volume":"21","author":"Gladding","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2012.11.016","article-title":"Phosphodiesterase 10A (PDE10A) localization in the R6\/2 mouse model of Huntington's disease","volume":"52","author":"Leuti","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib74","doi-asserted-by":"crossref","first-page":"e13417","DOI":"10.1371\/journal.pone.0013417","article-title":"Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease","volume":"5","author":"Giampa","year":"2010","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib75","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cellsig.2019.04.001","article-title":"PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders","volume":"60","author":"Whiteley","year":"2019","journal-title":"Cell Signal"},{"key":"10.1007\/s13311-019-00782-9_bib77","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.neuropharm.2010.10.025","article-title":"Huntington's Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)","volume":"60","author":"Subramaniam","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-019-00782-9_bib78","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1523\/JNEUROSCI.3730-12.2013","article-title":"Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease","volume":"33","author":"Mealer","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JHD-140094","article-title":"Rhes suppression enhances disease phenotypes in Huntington's disease mice","volume":"3","author":"Lee","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"10.1007\/s13311-019-00782-9_bib80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in huntington's disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron."},{"key":"10.1007\/s13311-019-00782-9_bib81","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nbd.2008.05.005","article-title":"Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease","volume":"31","author":"Desplats","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib82","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.celrep.2017.11.018","article-title":"Control of Huntington's disease-associated phenotypes by the striatum-enriched transcription factor Foxp2","volume":"21","author":"Hachigian","year":"2017","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J Chem Neuroanat"},{"key":"10.1007\/s13311-019-00782-9_bib84","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.410380605","article-title":"Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients","volume":"38","author":"Richfield","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-019-00782-9_bib86","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib87","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00782-9_bib88","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1523\/JNEUROSCI.2660-08.2008","article-title":"Dichotomous anatomical properties of adult striatal medium spiny neurons","volume":"28","author":"Gertler","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib89","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nn1972","article-title":"Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons","volume":"10","author":"Shen","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib90","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1073\/pnas.1004744108","article-title":"TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons","volume":"108","author":"Baydyuk","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3031","article-title":"BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior","volume":"4","author":"Besusso","year":"2013","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-019-00782-9_bib92","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.celrep.2019.02.003","article-title":"Cell-type-specific gene expression profiling in adult mouse brain reveals normal and disease-state signatures","volume":"26","author":"Merienne","year":"2019","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib93","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1073\/pnas.1417231112","article-title":"Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease","volume":"112","author":"Shema","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsys.2011.00046","article-title":"Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington's disease","volume":"5","author":"Andr\u00e9","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib95","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1523\/JNEUROSCI.0434-18.2018","article-title":"Striatal direct and indirect pathway output structures are differentially altered in mouse models of Huntington's disease.","volume":"38","author":"Barry","year":"2018","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsys.2014.00198","article-title":"Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease","volume":"8","author":"Deng","year":"2014","journal-title":"Front Syst Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0200626","article-title":"Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+\/\u2212 mouse model of Huntington's Disease","volume":"13","author":"Goodliffe","year":"2018","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib98","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib99","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","article-title":"Huntington's disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits","volume":"19","author":"Lim","year":"2017","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice","volume":"20","author":"Lim","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib101","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/gm369","article-title":"The expanding world of stem cell modeling of Huntington's disease: creating tools with a promising future","volume":"4","author":"Ward","year":"2012","journal-title":"Genome Med"},{"key":"10.1007\/s13311-019-00782-9_bib102","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1007\/s13311-019-00782-9_bib103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nbd.2011.12.032","article-title":"Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway","volume":"46","author":"Castiglioni","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib104","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"10.1007\/s13311-019-00782-9_bib105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mcn.2013.02.005","article-title":"Modeling Huntington's disease with induced pluripotent stem cells","volume":"56","author":"Kaye","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib106","first-page":"463","article-title":"CRISPR\/Cas9-mediated genome editing for Huntington's disease","volume":"2018","author":"Vachey","year":"1780","journal-title":"Methods Mol Biol"},{"key":"10.1007\/s13311-019-00782-9_bib107","article-title":"Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR\/Cas9 system.","volume":"6","author":"An","year":"2014","journal-title":"PLoS Curr"},{"key":"10.1007\/s13311-019-00782-9_bib108","first-page":"4566","article-title":"Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 editing of the mutant huntingtin allele in vitro and in vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-019-00782-9_bib110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib111","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mcn.2012.03.011","article-title":"Multiple phenotypes in Huntington disease mouse neural stem cells","volume":"50","author":"Ritch","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib112","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1603871113","article-title":"Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease","volume":"113","author":"Molero","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib113","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/embor.2010.182","article-title":"Is Huntington disease a developmental disorder?","volume":"11","author":"Humbert","year":"2010","journal-title":"EMBO Rep"},{"key":"10.1007\/s13311-019-00782-9_bib114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2016.11.035","article-title":"Huntingtin-mediated multipolar-bipolar transition of newborn cortical neurons is critical for their postnatal neuronal morphology","volume":"93","author":"Barnat","year":"2017","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.celrep.2018.09.076","article-title":"Human Huntington's disease iPSC-derived cortical neurons display altered transcriptomics, morphology, and maturation","volume":"25","author":"Mehta","year":"2018","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib116","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-019-00782-9_bib117","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41418-018-0060-4","article-title":"Exploring the genetics and non-cell autonomous mechanisms underlying ALS\/FTLD","volume":"25","author":"Chen","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1007\/s13311-019-00782-9_bib118","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1042\/BST20140168","article-title":"The non-cell-autonomous component of ALS: new in vitro models and future challenges","volume":"42","author":"Ferraiuolo","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1007\/s13311-019-00782-9_bib119","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1474-4422(08)70099-1","article-title":"Non-autonomous cell death in Parkinson's disease","author":"Dawson","year":"2008","journal-title":"Lancet Neurol Engl;"},{"key":"10.1007\/s13311-019-00782-9_bib120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.stemcr.2019.01.011","article-title":"Non-cell-autonomous neurotoxicity in Parkinson's disease mediated by Astroglial alpha-Synuclein","volume":"12","author":"Chai","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib121","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(78)90059-8","article-title":"Cortico-striate projections in the rhesus monkey: the organization of certain cortico-caudate connections","volume":"139","author":"Yeterian","year":"1978","journal-title":"Brain Res"},{"key":"10.1007\/s13311-019-00782-9_bib122","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1523\/JNEUROSCI.05-03-00776.1985","article-title":"Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey","volume":"5","author":"Selemon","year":"1985","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib123","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00782-9_bib124","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/exnr.1998.6888","article-title":"Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: evidence for increased synthesis and anterograde axonal transport","volume":"154","author":"Kokaia","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnhum.2016.00317","article-title":"Corticostriatal dysfunction in Huntington's disease: the basics","volume":"10","author":"Bunner","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410270217","article-title":"Degeneration of pyramidal projection neurons in Huntington's disease cortex","volume":"27","author":"Cudkowicz","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib127","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/WNL.41.7.1117","article-title":"Morphometric analysis of the prefrontal cortex in Huntington's disease","volume":"41","author":"Sotrel","year":"1991","journal-title":"Neurology"},{"key":"10.1007\/s13311-019-00782-9_bib128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-019-00782-9_bib129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cns.12828","article-title":"Corticostriatal network dysfunction in Huntington's disease: deficits in neural processing, glutamate transport, and ascorbate release","volume":"24","author":"Rebec","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1007\/s13311-019-00782-9_bib130","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","article-title":"A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease","volume":"24","author":"Puigdell\u00edvol","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib131","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1523\/JNEUROSCI.5284-12.2013","article-title":"Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease","volume":"33","author":"Murmu","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib132","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib133","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12035-013-8556-x","article-title":"Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6\/1 mouse model of Huntington's disease","volume":"49","author":"Anglada-Huguet","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-019-00782-9_bib134","first-page":"1255","article-title":"Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease","volume":"2016","author":"Anglada-Huguet","year":"1862","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1007\/s13311-019-00782-9_bib135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nbd.2005.05.008","article-title":"Depletion of rabphilin 3A in a transgenic mouse model (R6\/1) of Huntington's disease, a possible culprit in synaptic dysfunction","volume":"20","author":"Smith","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib136","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","article-title":"Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling","volume":"29","author":"Torres-Peraza","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib137","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn.4332","article-title":"The mouse cortico-striatal projectome","volume":"19","author":"Hintiryan","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib138","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1523\/JNEUROSCI.2812-14.2015","article-title":"Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease","volume":"35","author":"Estrada-Sanchez","year":"2015","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib139","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.22-15-06309.2002","article-title":"Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage","volume":"22","author":"Gorski","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cns.12844","article-title":"Disrupted striatal neuron inputs and outputs in Huntington's disease","volume":"24","author":"Reiner","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1007\/s13311-019-00782-9_bib141","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib142","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"10.1007\/s13311-019-00782-9_bib143","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib144","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00782-9_bib145","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-019-00782-9_bib146","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/glia.23022","article-title":"Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease","volume":"64","author":"Meunier","year":"2016","journal-title":"Glia"},{"key":"10.1007\/s13311-019-00782-9_bib147","first-page":"694","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat","volume":"17","author":"Tong","year":"2014","journal-title":"Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-5-17","article-title":"Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntingtons disease patient cells","volume":"5","author":"Juopperi","year":"2012","journal-title":"Mol Brain"},{"key":"10.1007\/s13311-019-00782-9_bib149","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.stem.2018.11.010","article-title":"Human ESC-derived chimeric mouse models of Huntington's disease reveal cell-intrinsic defects in glial progenitor cell differentiation","volume":"24","author":"Osipovitch","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1007\/s13311-019-00782-9_bib150","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-019-00782-9_bib152","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1523\/JNEUROSCI.17-09-03052.1997","article-title":"Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum","volume":"17","author":"Ferrante","year":"1997","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib153","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1007\/s13311-019-00782-9_bib154","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s13311-019-00782-9_bib155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib156","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-019-00782-9_bib157","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-019-00782-9_bib158","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0160295","article-title":"Correction: RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"11","author":"Labadorf","year":"2016","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib161","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"10.1007\/s13311-019-00782-9_bib162","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.2250-09.2009","article-title":"Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease","volume":"29","author":"Wacker","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib163","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib164","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant Huntingtin accumulation and Huntington's disease-associated phenotypes in vivo","volume":"90","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib165","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1093\/hmg\/ddx315","article-title":"IKK \u03b2 and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD","volume":"26","author":"Khoshnan","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib166","doi-asserted-by":"crossref","first-page":"621.e17","DOI":"10.1016\/j.neurobiolaging.2011.02.015","article-title":"Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons","volume":"33","author":"Kraft","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-019-00782-9_bib167","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/cercor\/bhr360","article-title":"Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease","volume":"22","author":"Di Paola","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-019-00782-9_bib168","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","article-title":"Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study","volume":"140","author":"Reading","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1007\/s13311-019-00782-9_bib169","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.neuroimage.2009.10.015","article-title":"Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical \u201cdisconnection\u201d","volume":"49","author":"Rosas","year":"2010","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-019-00782-9_bib170","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biopsych.2017.10.019","article-title":"Brain regions showing white matter loss in Huntington's disease are enriched for synaptic and metabolic genes","volume":"83","author":"McColgan","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-019-00782-9_bib171","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41598-017-00381-8","article-title":"Developmental whole brain white matter alterations in transgenic Huntington's disease monkey","volume":"7","author":"Meng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00782-9_bib172","first-page":"493","article-title":"Loss of Huntingtin-mediated BDNF gene transcription huntingtin-mediate in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Adv Sci"},{"key":"10.1007\/s13311-019-00782-9_bib173","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00782-9_bib174","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M109.084202","article-title":"Impaired TrkB-mediated ERK1\/2 activation in huntington disease knock-in striatal cells involves reduced p52\/p46 Shc expression","volume":"285","author":"Gin\u00e9s","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-019-00782-9_bib175","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1074\/jbc.M509806200","article-title":"Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons","volume":"281","author":"McGuire","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-019-00782-9_bib176","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/6.13.2205","article-title":"Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin","volume":"6","author":"Engelender","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib177","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","article-title":"Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport","volume":"17","author":"Conner","year":"1997","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib178","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain","volume":"23","author":"Gin\u00e9s","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib179","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-019-00782-9_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2013.116","article-title":"Imbalance of p75NTR\/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies","volume":"4","author":"Brito","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1007\/s13311-019-00782-9_bib181","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","article-title":"Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites","volume":"33","author":"Liot","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib182","first-page":"118","article-title":"Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal","volume":"228","author":"Baydyuk","year":"2011","journal-title":"dopaminergic degeneration."},{"key":"10.1007\/s13311-019-00782-9_bib183","doi-asserted-by":"crossref","first-page":"15491","DOI":"10.1073\/pnas.1212899109","article-title":"Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-019-00782-9_bib184","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1523\/JNEUROSCI.5100-09.2010","article-title":"Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth","volume":"30","author":"Rauskolb","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib185","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib186","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib187","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1007\/s12035-018-0890-6","article-title":"Brain-derived neurotrophic factor prevents depressive-like behaviors in early-symptomatic YAC128 Huntington's disease mice","volume":"55","author":"da Fons\u00eaca","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-019-00782-9_bib188","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/gt.2015.113","article-title":"AAV 1\/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease","volume":"23","author":"Connor","year":"2016","journal-title":"Gene Ther"},{"key":"10.1007\/s13311-019-00782-9_bib189","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","article-title":"BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease","volume":"17","author":"Giralt","year":"2010","journal-title":"Gene Ther"},{"key":"10.1007\/s13311-019-00782-9_bib190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-019-00782-9_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34883-w","article-title":"Decreased BDNF release in cortical neurons of a knock-in mouse model of Huntington's disease","volume":"8","author":"Yu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00782-9_bib192","doi-asserted-by":"crossref","first-page":"E5655","DOI":"10.1073\/pnas.1603020113","article-title":"TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease","volume":"113","author":"Zhao","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib193","first-page":"1","article-title":"Behavioral and transcriptome alterations in male and female mice with postnatal deletion of TrkB in dorsal striatal medium","author":"Unterwald","year":"2013","journal-title":"spiny neurons."},{"key":"10.1007\/s13311-019-00782-9_bib194","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron."},{"key":"10.1007\/s13311-019-00782-9_bib195","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","article-title":"Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination","volume":"34","author":"Fulmer","year":"2014","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib196","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fphys.2019.00486","article-title":"Effects of neurotrophic factors in glial cells in the central nervous system: expression and properties in neurodegeneration and injury","volume":"10","author":"Poyhonen","year":"2019","journal-title":"Front Physiol"},{"key":"10.1007\/s13311-019-00782-9_bib197","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-019-00782-9_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022966","article-title":"Brain-derived neurotrophic factor in patients with Huntington's disease.","volume":"6","author":"Zuccato","year":"2011","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib199","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.","volume":"24","author":"Canals","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2012.01.077","article-title":"Expression of mutant N-terminal huntingtin fragment (htt552-100Q) in astrocytes suppresses the secretion of BDNF","volume":"1449","author":"Wang","year":"2012","journal-title":"Brain Res"},{"key":"10.1007\/s13311-019-00782-9_bib201","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1523\/JNEUROSCI.0168-16.2016","article-title":"Mutant Huntingtin impairs BDNF release from astrocytes by disrupting conversion of Rab3a-GTP into Rab3a-GDP","volume":"36","author":"Hong","year":"2016","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199301000-00019","article-title":"Age dependence of striatal neuronal death caused by mitochondrial dysfunction","volume":"4","author":"Bossi","year":"1993","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-019-00782-9_bib203","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib204","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","article-title":"A mitochondria-associated oxidative stress perspective on Huntington's disease","volume":"11","author":"Zheng","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib205","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1074\/jbc.M807459200","article-title":"In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum","volume":"284","author":"Oliveira","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-019-00782-9_bib206","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/hmg\/ddv209","article-title":"Oxidative metabolism in YAC128 mouse model of Huntington's disease","volume":"24","author":"Hamilton","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib207","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00782-9_bib208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1\u03b1 in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-019-00782-9_bib209","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2015.02.004","article-title":"Selective striatal mtDNA depletion in end-stage Huntington's disease R6\/2 mice","volume":"266","author":"Hering","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib210","article-title":"Bioenergetic deficits in Huntington's disease iPSC-derived neural cells and rescue with glycolytic metabolites.","author":"Kedaigle","year":"2019","journal-title":"Hum Mol Genet."},{"issue":"2","key":"10.1007\/s13311-019-00782-9_bib211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JHD-180324","article-title":"Huntingtin aggregates and mitochondrial pathology in skeletal muscle but not heart of late-stage R6\/2 mice","volume":"8","author":"Kojer","year":"2019","journal-title":"J Huntingtons Dis"},{"key":"10.1007\/s13311-019-00782-9_bib212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11010-013-1951-9","article-title":"A mitochondrial basis for Huntington's disease: therapeutic prospects","volume":"389","author":"Chakraborty","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"10.1007\/s13311-019-00782-9_bib213","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2014.110","article-title":"Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: Critical role of astrocyte-neuron interactions","volume":"34","author":"Boussicault","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-019-00782-9_bib214","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","article-title":"Integrative characterization of the R6\/2 mouse model of Huntington's disease reveals dysfunctional astrocyte metabolism","volume":"23","author":"Skotte","year":"2018","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00782-9_bib215","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.drudis.2014.03.020","article-title":"Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission","volume":"19","author":"Reddy","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1007\/s13311-019-00782-9_bib216","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant Huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib217","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat Med"},{"key":"10.1007\/s13311-019-00782-9_bib218","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib219","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","article-title":"Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli","volume":"2","author":"Costa","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1007\/s13311-019-00782-9_bib220","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib221","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib222","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","article-title":"Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture","volume":"7","author":"Cooper","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib223","doi-asserted-by":"crossref","first-page":"18540","DOI":"10.1074\/jbc.RA118.004621","article-title":"N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting","volume":"293","author":"DeGuire","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-019-00782-9_bib224","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuron.2015.01.008","article-title":"N17 modifies mutant huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice","volume":"85","author":"Gu","year":"2015","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib225","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1172\/JCI80339","article-title":"Serine 421 regulates mutant huntingtin toxicity and clearance in mice","volume":"126","author":"Weiberth","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-019-00782-9_bib226","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/hmg\/ddi165","article-title":"Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo","volume":"14","author":"Warby","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-140106","article-title":"Kinase signalling in Huntington's disease","volume":"3","author":"Bowles","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"10.1007\/s13311-019-00782-9_bib228","first-page":"465","article-title":"Don't take away my P: phosphatases as therapeutic targets in Huntington's disease.","author":"Saavedra","year":"2012","journal-title":"In Ersoy Tunali (Ed.), Huntington's disease - core concepts and current advances. Intech,"},{"key":"10.1007\/s13311-019-00782-9_bib229","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev Cell"},{"key":"10.1007\/s13311-019-00782-9_bib230","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1523\/JNEUROSCI.0806-16.2016","article-title":"Compartment-dependent degradation of mutant huntingtin accounts for its preferential accumulation in neuronal processes","volume":"36","author":"Zhao","year":"2016","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib231","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1523\/JNEUROSCI.4393-08.2008","article-title":"Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons","volume":"28","author":"Tydlacka","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib232","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1523\/JNEUROSCI.1418-17.2017","article-title":"Mutant huntingtin inhibits \u03b1B-crystallin expression and impairs exosome secretion from astrocytes","volume":"37","author":"Hong","year":"2017","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib233","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00782-9_bib234","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00782-9_bib235","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1523\/JNEUROSCI.1464-07.2007","article-title":"PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors","volume":"27","author":"Cui","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib236","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1523\/JNEUROSCI.1312-10.2010","article-title":"The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit","volume":"30","author":"Zhang","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib237","doi-asserted-by":"crossref","first-page":"267120","DOI":"10.1100\/2012\/267120","article-title":"Distribution of extrasynaptic NMDA receptors on neurons","volume":"2012","author":"Petralia","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1007\/s13311-019-00782-9_bib238","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11251","article-title":"Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models","volume":"7","author":"Parsons","year":"2016","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-019-00782-9_bib240","doi-asserted-by":"crossref","first-page":"E8765","DOI":"10.1073\/pnas.1807962115","article-title":"Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition","volume":"115","author":"Siebzehnr\u00fcbl","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib241","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00782-9_bib242","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nm.3246","article-title":"Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models","volume":"19","author":"Marco","year":"2013","journal-title":"Nat Med"},{"key":"10.1007\/s13311-019-00782-9_bib243","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nbd.2012.07.001","article-title":"The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation","volume":"48","author":"Martinez-Turrillas","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib244","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000091921","article-title":"Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Ali","year":"2006","journal-title":"Dev Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib245","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos","volume":"354","author":"Cha","year":"1999","journal-title":"Trans R Soc Lond B Biol Sci"},{"key":"10.1007\/s13311-019-00782-9_bib246","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain"},{"key":"10.1007\/s13311-019-00782-9_bib247","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neurobiolaging.2003.04.003","article-title":"Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease","volume":"24","author":"Li","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-019-00782-9_bib248","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.neuroscience.2007.03.010","article-title":"Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease","volume":"147","author":"Benn","year":"2007","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-019-00782-9_bib249","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hipo.22995","article-title":"SAP97-mediated rescue of NMDA receptor surface distribution in a neuronal model of Huntington's disease","volume":"28","author":"Ambroziak","year":"2018","journal-title":"Hippocampus"},{"key":"10.1007\/s13311-019-00782-9_bib250","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/ejn.12202","article-title":"Decreased expression of GLT-1 in the R6\/2 model of Huntington's disease does not worsen disease progression","volume":"38","author":"Petr","year":"2013","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib251","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib252","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-019-00782-9_bib253","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain."},{"key":"10.1007\/s13311-019-00782-9_bib254","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib255","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib256","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nbd.2013.06.002","article-title":"Enhanced Ca2+\u2212dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model","volume":"58","author":"Lee","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00782-9_bib257","doi-asserted-by":"crossref","first-page":"e0214156","DOI":"10.1371\/journal.pone.0214156","article-title":"Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys","volume":"14","author":"Cho","year":"2019","journal-title":"PLoS One"},{"issue":"09","key":"10.1007\/s13311-019-00782-9_bib258","article-title":"Behavioral and electrophysiological improvements following up-regulation of GLT-1 in the Q175 Huntington's mouse.","volume":"418","author":"Bunner","year":"2016","journal-title":"Abstr Soc Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib259","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.14723","article-title":"Alterations in synaptic function and plasticity in Huntington disease.","volume":"150","author":"Smith-Dijak","year":"2019","journal-title":"J Neurochem."},{"key":"10.1007\/s13311-019-00782-9_bib260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000375126","article-title":"Dysfunctional dopaminergic neurones in mouse models of Huntington's disease: A role for SK3 channels","volume":"15","author":"Dallerac","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.1007\/s13311-019-00782-9_bib261","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190550","article-title":"MicroRNA signatures of endogenous Huntingtin CAG repeat expansion in mice","volume":"13","author":"Langfelder","year":"2018","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00782-9_bib262","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1038\/s41598-018-24243-z","article-title":"Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease","volume":"8","author":"Novati","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00782-9_bib263","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1152\/physiolgenomics.00125.2007","article-title":"Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models","volume":"33","author":"Brochier","year":"2008","journal-title":"Physiol Genomics"},{"key":"10.1007\/s13311-019-00782-9_bib264","doi-asserted-by":"crossref","first-page":"42875","DOI":"10.1038\/srep42875","article-title":"Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature","volume":"7","author":"Le Gras","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00782-9_bib265","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/ddx006","article-title":"High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds","volume":"26","author":"Ament","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib266","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1038\/s41598-018-28185-4","article-title":"Early alteration of epigenetic-related transcription in Huntington's disease mouse models","volume":"8","author":"Hervas-Corpion","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00782-9_bib267","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","article-title":"Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis","volume":"19","author":"Becanovic","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib268","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib269","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1093\/hmg\/ddr355","article-title":"Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative","volume":"20","author":"Fossale","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00782-9_bib270","first-page":"60","article-title":"A common gene expression signature in Huntington's disease patient brain regions","volume":"7","author":"Neueder","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1007\/s13311-019-00782-9_bib271","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1101\/gad.1436506","article-title":"Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle","volume":"20","author":"Riley","year":"2006","journal-title":"Genes Dev"},{"key":"10.1007\/s13311-019-00782-9_bib272","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/emboj.2008.23","article-title":"Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor","volume":"27","author":"Yamanaka","year":"2008","journal-title":"EMBO J"},{"key":"10.1007\/s13311-019-00782-9_bib273","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1007\/s13311-019-00782-9_bib274","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00782-9_bib275","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-019-00782-9_bib276","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-019-00782-9_bib277","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: histone modifications in Huntington's disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1007\/s13311-019-00782-9_bib278","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13148-011-0025-7","article-title":"Targeting Huntington's disease through histone deacetylases","volume":"2","author":"Gray","year":"2011","journal-title":"Clin Epigenetics"},{"key":"10.1007\/s13311-019-00782-9_bib279","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum Mol Genet"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00782-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:48:32Z","timestamp":1761806912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":279,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1878747923009625"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00782-9","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00782-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}